Nucleoside-Modified mRNA-LNP Therapeutics - Abramson Cancer Center Grand Rounds 2021-2022 - 6/1/2022

RSSAAPACMECNE

Add to Calendar Nucleoside-Modified mRNA-LNP Therapeutics - Abramson Cancer Center Grand Rounds 2021-2022 - 6/1/2022 6/1/2022 8:00:00 AM 6/1/2022 9:00:00 AM America/New_York false MM/DD/YYYY


Date & Location
Wednesday, June 1, 2022, 8:00 AM - 9:00 AM, Philadelphia, PA

Course Overview
The purpose of this educational activity is to provide a review of the pathophysiology and etiology of oncologic diseases.

Objective(s): 1 Discuss the mechanisms that give mRNA-LNP vaccines potent neutralizing antibody responses. 2 Describe the utility and potential uses of targeted LNP delivery of modified mRNA.
Location:
Specialties: PEDIATRICS, CLINICAL GENETICS AND GENOMICS (MD), INTERNAL MEDICINE - Hematology, NUCLEAR MEDICINE, OBSTETRICS AND GYNECOLOGY, INTERNAL MEDICINE - Medical Oncology, OPHTHALMOLOGY, RADIATION ONCOLOGY, UROLOGY, OTOLARYNGOLOGY, CLINICAL MOLECULAR GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, OBSTETRICS AND GYNECOLOGY - Gynecologic Oncology, PATHOLOGY - Clinical Informatics, PATHOLOGY - Pathology-Molecular Genetic, PEDIATRICS - Pediatric Hematology-Oncology, RADIOLOGY - Nuclear Radiology, SURGERY - Complex General Surgical Oncology

Faculty Disclosures:
Drew Weissman, MD (Nothing to disclose - 05/13/2022)
Download Handout

Target Audience
Specialties - CLINICAL GENETICS AND GENOMICS (MD), CLINICAL MOLECULAR GENETICS AND GENOMICS, INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, NUCLEAR MEDICINE, OBSTETRICS AND GYNECOLOGY, OBSTETRICS AND GYNECOLOGY - Gynecologic Oncology, OPHTHALMOLOGY, OTOLARYNGOLOGY, PATHOLOGY - Clinical Informatics, PATHOLOGY - Pathology-Molecular Genetic, PEDIATRICS, PEDIATRICS - Pediatric Hematology-Oncology, RADIATION ONCOLOGY, RADIOLOGY - Nuclear Radiology, SURGERY - Complex General Surgical Oncology, UROLOGY


Objectives

After completing this activity, participants should be able to:


  1. Discuss the mechanisms that give mRNA-LNP vaccines potent neutralizing antibody responses.
  2. Describe the utility and potential uses of targeted LNP delivery of modified mRNA.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

All activities listed on this transcript have been approved for AMA PRA Category 1 Credit™.


Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), American Academy of Physician Assistants (1.00 hours)